Recent News

• 04.02.2025 - Immunocore to present at upcoming investor conferences
• 03.10.2025 - Immunocore presents initial multiple ascending dose data for HIV functional cure candidate in an oral presentation at CROI 2025
• 03.03.2025 - Immunocore to present at upcoming investor conferences
• 02.26.2025 - Immunocore reports fourth quarter and full year 2024 financial results and provides a business update
• 02.19.2025 - Immunocore to report fourth quarter and full year 2024 financial results and host call on February 26, 2025

Recent Filings

• 03.24.2025 - PRE 14A Other preliminary proxy statements
• 03.19.2025 - 4 Statement of changes in beneficial ownership of securities
• 03.17.2025 - 424B7 Prospectus [Rule 424(b)(7)]
• 03.17.2025 - 144 Report of proposed sale of securities
• 03.17.2025 - POSASR Post-effective Amendment to an automatic shelf registration statement
• 03.17.2025 - 8-K Current report
• 03.14.2025 - 144 Report of proposed sale of securities
• 03.10.2025 - EX-99.1 EX-99.1
• 03.10.2025 - 8-K Current report
• 02.27.2025 - 3 Initial statement of beneficial ownership of securities